iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults

Part of paid clinical trials in New Port Richey, Florida.

Sponsor
Synbiotic Health
Study ID
NCT07407894
Status
Recruiting
Apply to this trial

Conditions

  • Anti Aging
  • Healthy Aging

Eligibility Criteria

Sex
ALL
Age
40 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • Bifidobacterium adolescentis iVS-1 — DIETARY_SUPPLEMENT
    B. adolescentis iVS-1 (probiotic capsule) delivered orally once daily at a minimum of 8 billion CFU/day
  • Placebo — DIETARY_SUPPLEMENT
    Placebo capsule delivered orally once daily

Study Details

This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.

Key Dates

Start date
Feb 1, 2026
Status verified
Apr 2026
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Bifidobacterium adolescentis iVS-1
    Probiotic Capsule
  • Placebo Comparator: Placebo
    Placebo capsule

Primary Outcome Measure

Change in Biological Aging Biomarkers [ Time Frame: Baseline to Day 150 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MusB Research LLCNew Port RicheyFlorida34638
Shalini Jain, PhD
[email protected]
813-419-0781
Shalini Jain, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New Port Richey, FL

By research site
MusB Research LLC· New Port Richey, FL

Related Studies